Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Operating Expenses (2023)

Anaptysbio's Other Operating Expenses history spans 1 years, with the latest figure at $7.3 million for Q4 2023.

  • For Q4 2023, Other Operating Expenses changed N/A year-over-year to $7.3 million; the TTM value through Sep 2024 reached $7.3 million, changed N/A, while the annual FY2023 figure was $7.3 million, N/A changed from the prior year.
  • Other Operating Expenses reached $7.3 million in Q4 2023 per ANAB's latest filing.
  • In the past five years, Other Operating Expenses ranged from a high of $7.3 million in Q4 2023 to a low of $7.3 million in Q4 2023.